View post tag: conduct The “Wizards” of Electronic Attack Squadron (VAQ) 133 conducted an aerial change of command ceremony over the Nimitz-class aircraft carrier USS John C. Stennis (CVN 74) March 17.Cmdr. Mike Bisbee, of Miami, Fla., relieved Cmdr. Christopher DeMay, of Farmingdale, N.Y., as commanding officer. Bisbee previously served as VAQ-133’s executive officer.“I was very fortunate to have an outstanding group of officers, chief petty officers and enlisted Sailors,” said DeMay. “The squadron had a tremendous reputation before I took command and it was a challenge to maintain that reputation and team spirit. He [Bisbee] has been a great XO, friend and sounding board for me during my time here,” said DeMay.DeMay’s next assignment will be as executive assistant at Commander, U.S. Fleet Cyber Command in Fort Meade, Md.“He was an outstanding skipper, one of the best I’ve worked with,” said VAQ-133 Command Master Chief Matt Miesle, from Elmore, Ohio. “I think the crew is sad to see him go, but he is handing over a very successful squadron to very capable hands, and I can’t think of anyone better than Cmdr. Bisbee.”While still supporting the mission at hand, Bisbee looks forward to returning to Naval Air Station Whidbey Island and leading the squadron through the upcoming transition from the EA-6B Prowler to the EA-18G Growler.“First and foremost my goal is to get everyone home,” said Bisbee. “After two back-to-back deployments I want everyone to be able to take time off with loved ones when we return before we start the transition.”VAQ-133 is currently assigned to Carrier Air Wing (CVW) 9 aboard Stennis and has been in the 5th Fleet area of responsibility (AOR) providing support to Operation Enduring Freedom since Oct. 18, 2012.The John C. Stennis Carrier Strike Group, consisting of Stennis, CVW-9, Destroyer Squadron 21 and guided-missile cruiser USS Mobile Bay (CG 53), is deployed to the U.S. 5th Fleet AOR to strengthen regional partnerships, sustain maritime security, and support combatant commander requirements for assets in the area.[mappress]Naval Today Staff, March 19, 2013 Training & Education View post tag: Defence View post tag: Command View post tag: Stennis View post tag: change View post tag: C. ‘Wizards’ Conduct Aerial Change of Command Ceremony over USS John C. Stennis View post tag: News by topic Share this article View post tag: Ceremony View post tag: over View post tag: Defense View post tag: Naval View post tag: John View post tag: Navy View post tag: Aerial View post tag: USS Back to overview,Home naval-today ‘Wizards’ Conduct Aerial Change of Command Ceremony over USS John C. Stennis March 19, 2013 View post tag: “Wizards”
View post tag: Royal Navy View post tag: North Korea View post tag: HMS Albion Share this article Royal Navy sending third warship to Asia Pacific Authorities Back to overview,Home naval-today Royal Navy sending third warship to Asia Pacific The UK defense ministry confirmed on Wednesday it is sending amphibious transport dock HMS Albion to North East Asia to support UN sanctions against the Democratic People’s Republic of Korea (DPRK).Albion set sail from the Devonport Naval Base in February this year and was initially scheduled to spend five months in the Mediterranean Sea as flagship of NATO’s Standing Maritime Group 2 (SNMG2).Neither the navy nor the defense ministry explained why this change of tasking occurred.Captain Tim Neild, HMS Albion commanding officer, said: “It is a huge privilege for us to fly the flag of the NATO task group commander in such a high profile deployment.Albion is the third Royal Navy ship to be sent to the Asia-Pacific region.Type 23 frigate HMS Sutherland has already started its engagements in the region and is currently on a port call in Yokosuka, Japan. Another Type 23 frigate, the HMS Argyll, will join the two later this year.“Until North Korea matches its words with concrete actions, the UK will continue working closely with partners and allies to keep up pressure and strictly enforce existing sanctions, ensuring not only regional security but that of the UK as well,” Defence Secretary Gavin Williamson said.In the coming months HMS Albion, alongside HMS Sutherland, will be contributing to international efforts to monitor prohibited trading at sea by the DPRK, which provides a major source of funding for its illegal nuclear program.While in the region, both vessels will visit several ports and take part in joint training with allies and partners, including the US, the Republic of Korea and Japan.“I am delighted to support UK interests in the Asia-Pacific. Our deployment serves as a fantastic example of the flexibility and global reach of the Royal Navy,” Captain Tim Neild, the commanding officer of HMS Albion, said. “As always, I am extremely grateful for the ongoing support from our families and friends back home as we carry out these important international responsibilities on the other side of the world.”The deployment of these three ships will mean that the Royal Navy will have a vessel in the strategically critical Asia-Pacific region for the first time since 2013 and will have an almost unbroken presence there this year.Once HMS Argyll arrives in Asia Pacific, she is set to participate in a Five Power Defence Arrangements exercise with Australia, Malaysia, New Zealand and Singapore before also travelling to North East Asia for further joint training and exercises. April 11, 2018
The wake in remembrance of Michael Joseph Coleman, 85, will be held Wednesday July 5 from 7 to 9 p.m., at the Lawton-Turso Funeral Home, 7th and Washington streets, Hoboken. A memorial mass will take place Thursday July 6 at 2 p.m. in St. Francis Church, 3rd and Jefferson Sts., Hoboken.He passed away peacefully June 16 at the VA hospital in East Orange. A long-time resident of Hoboken, Michael was born in St. Paul, Minn. and attended St. Thomas College before serving in Korea as a member of the Air Force. He returned to school to earn an MA degree in Industrial Relations, then piloted for Eastern Airlines. In 1959, he accepted a position as President of the Young Christian Workers in Chicago followed by work with the Commission for Economic Development, a group providing support to developing nations.In 1965 Mike worked for the US Economic Development Administration, Dept. of Commerce in civil rights compliance. Michael came to Hoboken in 1968 to serve as executive director of the Model Cities Program, an effort of the Johnson Administration for urban renewal of inner cities. For eight years he was instrumental in starting the dynamic revitalization of Hoboken that continues today. Following his work with Model Cities, Mike founded a consulting business, Michael Coleman Associates. Michael was a diligent practitioner of Tai Chi, loved flying, sailing and spending time helping his friends and family.He is survived by his children and extended family: first wife, Rae Barsotti Coleman; Michael and Yvonn Coleman; Jennifer and Ted Norman; Suzanne and Flip Herndon; son James who died in 2005, and son Steven; his eight grandchildren: Alexander and Sebastian; Delaney, Eve, and Colin; Coleman, Mason, and Miles; his brother Pat and wife, Judy and their children; and in memoriam, his brother, George, who died in 1982, survived by his wife, Joann and two children; along with many nieces and nephews spread around the country.Services arranged by the Lawton-Turso Funeral Home, Hoboken.
I attended the only formal Transport Council under the Bulgarian Presidency (the Presidency) in Luxembourg on Thursday 7th June.The Council reached a general approach on a proposal to revise the current Regulation on safeguarding connectivity and competition in international air transport, which is intended to provide protection against subsidisation and unfair pricing practices in the supply of air services from non-EU countries. During the discussion, I emphasised the importance of connectivity, consumer choice and avoiding market distortions.Following this, the Council adopted the Presidency’s proposal for a general approach on the directive on port reception facilities. I supported the aim to further protect the marine environment against illegal discharges of waste from ships and to ensure the efficiency of maritime operation in ports, and recognised that concerns raised by the UK had been addressed.Next, the Presidency presented a progress report on the revised rail passengers’ rights and obligations regulation, which was noted by the Council.Following this, the Council considered a number of files in phase one of the mobility package (published in May 2017). Firstly, the Presidency concluded that the Council had reached a general approach on the compromise proposal on the revised European electronic road tolling services (‘EETS’) directive, on which I voiced my support. Next, when considering the proposed directive on hired goods vehicles, the Presidency observed it did not have sufficient support for a general approach and concluded that the Council was unable to adopt the proposal. In the discussion, I noted that the UK supported the general approach, but acknowledged that other member states wanted further discussion.Over lunch, ministers discussed the financing of infrastructure projects in the EU and connectivity in the Western Balkans.Following this, the Presidency presented progress reports on the remaining elements of phase one of the mobility package, covering proposals designed to improve the clarity and enforcement of the EU road transport market (the ‘market pillar’), and proposals on the application of social legislation in road transport (the ‘social pillar’). I outlined the outstanding areas of concern for the UK and committed to working constructively toward a general approach and deal moving forward.Next, the Presidency presented 2 progress reports on proposals from phase two of the mobility package (published November 2017). The Presidency provided updates on the proposal to amend the current combined transport directive, which aims to encourage and facilitate modal shift away from the roads and onto alternative means of transport, and to reduce congestion, and the clean and energy-efficient vehicles directive.Under any other business, several items were discussed. Notably, Commissioner Bulc presented the third and final mobility package proposals, which focused on safety and technology in transport. Commissioner Bulc also presented an action plan on military mobility; in reply to Luxembourg, she confirmed that a range of actions were being pursued under the EU cycling strategy and, in reply to Finland, set out plans for an upcoming public consultation on summertime arrangements. Furthermore, Sweden noted the 18 to 19 June summit on connected and autonomous vehicles in Gothenburg; and Austria presented transport plans for its incoming Presidency of the Council of the European Union.Regarding bilateral engagement, I met with Commissioner Bulc and my ministerial counterparts from Austria, Belgium, Bulgaria, Denmark, Finland, France, Germany, Netherlands, Malta, Poland and Romania.
To achieve the MAA’s vision to be a world class military air safety regulatory and assurance organisation that is proactive, innovative, modern, efficient and effective, there is a continuing need to examine our approach. The attached document contains the full article.
NEW DELHI (AP) — Popular short-video Chinese app TikTok is cutting its workforce in India after hundreds of millions of its users dropped it to comply with a government ban on dozens of Chinese apps amid a military standoff between the two countries. A TikTok statement expressed the hope the company will get a chance to relaunch the app in India to support hundreds of millions of users, artists, storytellers, educators and performers. The statement didn’t give details, but media reports say it has more than 2,000 employees in India. China says New Delhi is using national security as an excuse to prohibit Chinese mobile apps.
# # # Shelburne Museum has been selected to receive the 2009 Award for Outstanding Commitment to the Preservation and Care of Collections. The national award, presented to just two museums this year, is determined by a panel of distinguished conservation experts from across the country and is presented jointly by Heritage Preservation and the American Institute for Conservation of Historic Artistic Works. The other recipient was Historic Cherry Hill in Albany, NY.“We are honored to be recognized by our peers for our work in caring for the many and varied collections at Shelburne Museum,” said Rick Kerschner, director of preservation and conservation at Shelburne Museum. “The museum’s diverse collection coupled with the environmental challenges presented by Vermont’s climate make our work both challenging and rewarding.”Eryl Wentworth, Executive Director of the American Institute for Conservation of Historic and Artistic Works, presents the 2009 Award for Outstanding Commitment to the Preservation and Care of Collections to Rick Kerschner, director of preservation and conservation at Shelburne Museum. The national award was presented on Friday, Sept. 25 and was awarded jointly by the Heritage Preservation. Pictured from left to right are: Stephan Jost, director; Nancie Ravenel, objects conservator; Rick Kerschner, director of preservation and conservation; Eryl Wentworth, executive director of the American Institute for Conservation of Historic and Artistic Works; James Pizzagalli, chairman of the board of trustees; Michael Polemis, board member and chairman of the museum’s Collections Committee.Shelburne Museum was selected for showing a sustained and exemplary commitment to preserving America’s heritage and for enriching the community by caring for its unique and varied collections through dedicated planning and effort. Those efforts include the gamut of collections care from innovative lighting to environmental control and security measures that allow the public safe access to artifacts.“The committee was especially impressed by the museum’s creativity and innovative thinking in caring for such a unique and varied collection,” said Eryl Wentworth, Executive Director of the American Institute for Conservation of Historic and Artistic Works. She also applauded the museum’s “long standing commitment to preserving its extraordinary collection.”The Conservation Department was established in 1983. Shelburne was singled out for developing a plan for the museum’s unique collections that includes buildings, carriages, a lighthouse, a covered bridge and a steamboat. The museum was also recognized for enriching the field of conservation and collection care under the tutelage of Kerschner and Object Conservator Nancie Ravenel.Over 25 years, 61 conservators have been trained at the museum. Public outreach through exhibits and fundraising programs, such as the Adopt a Carousel Animal program, have raised awareness of the museum and the importance of conservation.The Award for Outstanding Commitment to the Preservation and Care of Collections has been presented annually since 1999. Previous recipients include Colonial Williamsburg and the Museum of Fine Arts, Boston.About Shelburne Museum: Located in Vermont’s scenic Lake Champlain Valley, Shelburne Museum is one of the nation’s finest, most diverse and unconventional museums of art, design and Americana. Over 150,000 works are exhibited in a remarkable setting of 39 exhibition buildings, 25 of which are historic and were relocated to the museum grounds. The American Institute for Conservation of Historic and Artistic Works is the national membership organization of professional conservators dedicated to preserving the art and historic artifacts of our cultural heritage for future generations. Heritage Preservation is a nonprofit organization dedicated to preserving our nation’s heritage. Its members include museums, libraries, archives, and other organizations concerned with saving the past for the future. Source: SHELBURNE, Vermont (Sept. 25, 2009) Shelburne Museum.
Mar 3, 2008 (CIDRAP News) – Health officials in Egypt announced on Mar 1 that a 25-year-old woman who is hospitalized with severe respiratory symptoms has an H5N1 avian influenza infection.Abdel Rahman Shaheen, spokesman for Egypt’s health ministry, said in a statement from MENA, the country’s state news agency, that tests on Mar 1 confirmed that the woman’s samples were positive for the virus, according to a report from Reuters. If the woman’s illness is confirmed by the World Health Organization (WHO), she will be listed as Egypt’s 45th H5N1 case-patient.Shaheen said the woman had been transferred from Fayoum governorate, about 53 miles south of Cairo, to a hospital in the country’s capital, where she is being treated with oseltamivir (Tamiflu), an antiviral medication, Reuters reported. He said she had a high fever and inflammation of both lungs.News reports on the woman’s illness gave no details on the source of her infection.The woman is the second Egyptian patient in a week to be reported as sick with an H5N1 infection. On Feb 26 health officials announced that samples from a 4-year-old girl from Menia governorate in upper Egypt were positive for the H5N1 virus.In a Feb 28 statement, the WHO said the girl got sick on Feb 21 and was hospitalized 3 days later. The statement from MENA said the girl is still hospitalized in Cairo, where she is in stable condition, according to a report yesterday from Xinhua, China’s state news agency.An investigation into the source of the girl’s infection revealed that she had contact with sick poultry the week before she became ill, according to the WHO statement. She is listed as Egypt’s 44th case-patient. The disease has been fatal in 19 of those. See also:Feb 28 WHO statement
Oct 23, 2009 (CIDRAP News) – Questions about the tardy US supply of pandemic H1N1 vaccine have increased with the report that most of Novartis’s doses may not reach the country until early in 2010 and a European regulatory recommendation that may have implications for the global vaccine supply.Novartis Chief Executive Officer Daniel Vasella said yesterday that most of the company’s vaccine supply may not be delivered until the first quarter of 2010, Bloomberg News reported yesterday. Vasella made the comments in an interview on CNBC.Novartis has a $979 million contract to supply H1N1 vaccine to the US Department of Health and Human Services (HHS). The company is expected to supply about 35% of the total projected US supply of about 251 million doses, the Bloomberg story said.Today, the European Union’s drug regulatory agency announced it would maintain an earlier recommendation for a two-dose regimen of the three H1N1 vaccines approved in the EU, despite data showing one-dose efficacy for two of the vaccines. The recommendation raises the possibility of a major increase in European demand for the vaccines, with possible repercussions for the US supply.The vaccines covered by the EU recommendation are Novartis’s Focetria, GlaxoSmithKline’s (GSK’s) Pandemrix, and Baxter’s Celvapan. Novartis makes both its US and European H1N1 vaccines in Europe. GSK is under contract to supply some doses to the United States, but it accounts for only a small share of the total supply.Slow flow of vaccineThe flow of vaccine to US providers has been far below earlier projections. At a news briefing today, Dr. Tom Frieden, director of the Centers for Disease Control and Prevention (CDC), said a total of 16.1 million doses have become available for distribution so far. Yesterday Dr. Anne Schuchat of the CDC predicted that the number will reach 28 million doses by the end of this month.Back in July, HHS had projected that 120 million doses of vaccine would be ready in October. But in mid-August that was trimmed to a predicted 45 million doses by mid-October, after manufacturers found that the egg-based vaccine production process was not yielding nearly as much virus as expected.A factor that initially hampered accurate vaccine production projections was the lack of a good test for measuring the amount of vaccine antigen produced, said Dr. Bruce Gellin, director of HHS’s National Vaccine Program Office, at yesterday’s meeting of the CDC Advisory Committee on Immunization Practices (ACIP). He said it wasn’t until late August that an accurate assay for measuring the amount of hemagglutinin became available.At today’s CDC briefing, Frieden said that though vaccine availability is increasing steadily, it’s coming far too slowly.”Vaccine production is nowhere near where we thought it would be,” he said. “Vaccine is our strongest tool, and not having enough of it is frustrating for all of us.”He said manufacturers are working as hard as they can to get as much vaccine out as safely as possible, but vaccine production is as unpredictable as viruses. When the first doses of the vaccine were coming off production lines, he said, officials had to make a tough ethical decision: let supplies build or distribute it right away.”The alternative would be to let it stock up until we have enough for larger populations of people who wanted to get it,” he said. “Doing that would have meant it would be waiting in warehouses when people who want to get vaccinated could be protected.”The CDC is aware of reports of people not being able to get the vaccine, Freiden said. “On the flip side, there is a lot of interest in the vaccine, and we’re glad to see that,” he stated. National polls conducted earlier this fall showed lukewarm interest in the vaccine, though parents seem somewhat more willing to have their children vaccinated than themselves.A reporter asked Frieden if he thought the EU’s recommendation for a two-dose regimen of H1N1 vaccine would affect the United States’ supply of vaccine, much of which comes from Europe. He said US officials aren’t worried, because vaccine data affirm one-dose efficacy. “Our supplies are already preordered and it’s a question of when they get delivered. I don’t think that [the EU decision] would be a consideration,” he said.Dr. Michael Perdue, director of influenza and emerging diseases at the HHS Office of the Assistant Secretary for Preparedness and Response, when asked about the EU recommendation today, told CIDRAP News, “So far we haven’t been told that our order with Novartis is going to be affected in any way.” He said he couldn’t immediately comment further.The EU recommendation for two doses per person was not absolute. The Committeee for Medicinal Products for Human Use (CMPH) said it decided to maintain an initial recommendation that the three vaccines “be preferably used as two doses, three weeks apart.” However, for the Novartis and GSK vaccines, “the limited data currently available indicate that one dose may be sufficient in adults,” the committee said.Frieden, when pressed today about which companies are having production delays, reiterated that it’s not unusual for manufacturers to encounter delays, which have occurred periodically with the seasonal flu vaccine. “Each different supplier has its own challenges,” he added.Frieden said vaccine supply would become more plentiful in the next several weeks, but he held off on making any projections. “Given how far off some of the projections have been from what we have now, I would prefer to just take it one day at a time, one week at a time,” he said.Manufacturers’ assessmentsVaccine manufacturers are currently wary of making specific predictions about when they will finish producing all their doses, but they say they are working hard to meet their contracts.Novartis spokesman Eric Althoff told CIDRAP News today that the company expects to finish making bulk vaccine by the end of the year, but he declined to predict when all the finished doses will be ready.Sanofi Pasteur is under contract to make 75.3 million doses of H1N1 vaccine, about 30% of the expected US supply, at its facilities in Swiftwater, Pa. Company spokeswoman Donna Cary said today that Sanofi expects to finish making bulk vaccine in December.In an e-mailed statement, Cary said, “We have orders for 75.3 million doses of bulk antigen for anticipated delivery between October and December. We are on track to deliver this by December. In fact, of the 16 million doses HHS reports they have available, Sanofi Pasteur shipped 12 million.”Cary said the company has succeeded in “optimizing” the vaccine seed virus to improve yields. “We are pleased to report that yields are now exceeding the yield projections used in early production planning with HHS. In fact, current yields are now close to our seasonal standard. Thus, we do not anticipate the strain yield to be a factor impacting future production schedules.”The company also was able to speed up the licensure of two new filling lines that were not originally scheduled to be licensed until later, boosting filling capacity, Cary reported.MedImmune is under contract to make about 40 million doses of its intranasal, live attenuated H1N1 vaccine for HHS. The company said earlier it did not have the yield problems that other manufacturers reported.Company spokeswoman Karen Lancaster said today, “We’re pretty much on track. We had anticipated about 11 million doses by the end of October, and we’re pretty much on track to deliver that. I can also say we’ve made enough bulk vaccine to fill all the orders, and we’re now working around the clock to get those into sprayers and packaged and delivered.”She said the company’s delivery schedule goes through early 2010, but she couldn’t be more specific about a projected date for finishing production.Another US suppilier is Australian-based CSL Biotherapies. According to the Bloomberg story, a company official said on Oct 20 that the firm was on scheduled to deliver its 36 million doses.
The beginning of October is reserved for the 10th jubilee edition of the Congress World Medical Tourism & Global Healthcare Congress in Los Angeles where the Bagatin Polyclinic is in the role of a gold sponsor. It is the most comprehensive international conference on health that brings together participants from around the world and focuses on cooperation and improvement of the industry itself, and the organizer of the event is Medical Tourism Association, the first international non-profit association for health tourism and the global health industry.The conference brings together top international hospitals, health care providers, facilitators, insurance companies and other related companies with the common goal of promoting the highest quality of patient health care in a global environment, and this year will bring together 200 exhibitors, over 2000 visitors and 150 speakers. The company will be visited by the director of the Bagatin Polyclinic, Mr. Ognjen Bagatin.“With a very interesting lecture entitled ‘Bringing more visibility to medical travel brand’, they will present the success story of the Bagatin Polyclinic on the international market and the (thorny) path we have taken – from branding the destination as additional value for clients to branding the Polyclinic service. 7 Bagatin’s branding laws are sure to inspire and guide someone on the right path. They will also have the opportunity to participate in panel discussions from which we would like to single out one particularly interesting topic ‘Health Googlocity: The ins and outs of marketing health and wellness’ ” stand out from the Bagatin PolyclinicThe strength of togetherness and synergy was recognized by other partners who will join in a joint performance this year. In addition to the Bagatin Polyclinic, which is known as an international polyclinic, Croatia will also be represented by the Zagreb Tourist Board. Jadranka Primorac, member of the Management Board of the Special Hospital Sv. Katarina, as a panelist on the topic ‘Lessons Learned: Our Journey Towards Accreditation in Medical Travelte’ and Mr. Zdeslav Radovčić, founder and president of the HTI Conference for Medical Tourism. During the three-day congress, our exhibition space will be visited by thousands of congress participants from all over the world, to whom the Bagatin Polyclinic will present all the services, but also the numerous opportunities offered by Croatia. “The goal is to attract large employers and their representatives from all over the world who would send their employees for treatment to top clinics that Croatia can boast of. ” conclude from the Bagatin Polyclinic. Certainly this is a new opportunity to promote Croatia and the city of Zagreb as a destination for health tourismISO certificate – a new confirmation of the quality of the Bagatin PolyclinicOn September 05, 2017, the Bagatin Polyclinic became the proud holder of the ISO 9001: 2015 quality management certificate and, after several months of preparations, successfully completed the certification audit. ISO 9001 is the most widespread international standard that sets requirements for the establishment and maintenance of quality management systems.Certification of this system is a generally accepted way of proving to a current and potential partner that a product or service will meet its quality requirements. “By introducing a quality management system, we want to provide all our clients with top service at the level of 5-star hotels every time they arrive at the Bagatin Polyclinic. Our goal is to improve these figures on a daily basis in order to correspond to the real situation in the operational and strategic activities of our Polyclinic. ” stand out from the Bagatin Polyclinic.